HBOT for Longevity and Performance: Anti-Aging, Athletes, and Biohacking

A growing body of evidence suggests HBOT can influence biological aging markers, including telomere length and senescent cell accumulation. The landmark Efrati study (2020, published in Aging) showed 20-38% increases in telomere length and 11-37% decreases in senescent cells after 60 sessions at 2.0 ATA. This page covers what the science actually shows, what it does not show, and how biohackers and longevity-focused patients are using HBOT in practice.

The Anti-Aging Evidence

Telomere Lengthening

Telomeres are protective caps on the ends of chromosomes that shorten with each cell division. Shorter telomeres are associated with aging and age-related diseases. The Efrati study (Efrati et al., 2020, published in Aging) enrolled 35 healthy adults aged 64+ in a protocol of 60 HBOT sessions at 2.0 ATA with 100% oxygen, including intermittent hypoxic-hyperoxic intervals.

Results showed significant increases in telomere length across multiple immune cell types: 20% increase in B cells, 37% in helper T cells, 30% in cytotoxic T cells, and 38% in natural killer cells. This was the first intervention shown to reverse telomere shortening in a controlled human study.

Senescent Cell Clearance

Senescent cells are “zombie cells” that stop dividing but refuse to die, accumulating with age and secreting inflammatory molecules (the senescence-associated secretory phenotype, or SASP). The same Efrati study showed 11-37% reductions in senescent cells across different immune cell types after HBOT.

This puts HBOT in the category of senolytic interventions, alongside drugs like dasatinib+quercetin (D+Q) and fisetin, but through a completely different mechanism: oxygen-driven cellular signaling rather than pharmaceutical targeting.

Cognitive Enhancement in Healthy Aging

Beyond cellular markers, Efrati’s group has shown that the same HBOT protocol improves cognitive function, cerebral blood flow, and brain perfusion in healthy aging adults. Participants showed improvements in attention, information processing speed, and executive function, with corresponding increases in brain perfusion measured by MRI.

What the Evidence Does NOT Show

Honest assessment requires noting what the current evidence does not support:

• Soft chambers have not been shown to produce these effects. The Efrati anti-aging studies used 2.0 ATA in a hard chamber with 100% oxygen and intermittent oxygen fluctuations. There is no published evidence showing telomere lengthening or senescent cell reduction from mild HBOT at 1.3 ATA. For more on this distinction, see our analysis of why soft chambers are oversold for clinical outcomes.
• Long-term durability is uncertain. The telomere and senescent cell changes were measured immediately post-protocol. We do not yet know how long these changes persist or whether maintenance sessions are needed.
• The oxygen fluctuation component has not been isolated. The Efrati protocol uses intermittent hypoxic-hyperoxic intervals. It is unclear whether steady-state 2.0 ATA HBOT (without fluctuations) would produce the same results.
• The sample size was small. Thirty-five participants. This is a promising signal, not definitive proof.
• No lifespan data exists. Telomere lengthening and senescent cell clearance are biomarkers of aging, not proof of extended lifespan or healthspan.

HBOT for Athletic Performance and Recovery

Professional athletes have used HBOT for decades. LeBron James, Cristiano Ronaldo, Michael Phelps, and numerous NFL players have publicly used hyperbaric chambers for recovery between games and accelerating injury healing.

The proposed mechanisms for athletic use:

• Faster recovery between training sessions: Increased oxygen delivery reduces muscle soreness and accelerates lactate clearance
• Injury repair: Enhanced angiogenesis and collagen synthesis support faster healing of sprains, fractures, and soft tissue injuries
• Reduced inflammation: Suppression of pro-inflammatory cytokines after intense training
• Concussion recovery: Neuroplasticity benefits for athletes in contact sports (see our HBOT for concussion guide)

The evidence quality for athletic performance enhancement is mixed. There are positive case series and observational data, but few randomized controlled trials specifically in healthy athletes. The strongest evidence is for injury recovery, not performance enhancement during training.

Biohacker Protocols

The biohacking and longevity community has adopted HBOT as a core protocol. Common approaches include:

• Efrati-style aging protocol: 60 sessions at 2.0 ATA (the full research protocol, typically at Aviv Clinics or a clinic with hard chambers)
• Maintenance protocol: 1-2 sessions per week at 1.5-2.0 ATA after completing an initial course, intended to maintain benefits
• Home soft chamber: Daily or several-times-weekly sessions at 1.3 ATA for general wellness (lower evidence base, lower cost)
• Stacking with other interventions: HBOT combined with IV NAD+, ozone therapy, or peptides for multi-pathway longevity approaches

The Bryan Johnson “Blueprint” protocol and other high-profile longevity programs have increased public awareness of HBOT for anti-aging, though the specific protocols used by public figures are not always disclosed in detail.

Cost of HBOT for Longevity

Anti-aging HBOT is not covered by insurance (it is not an FDA-cleared indication). Expect to pay entirely out of pocket:

• Full Aviv Clinics program (Efrati protocol): $20,000-$60,000+ (includes cognitive and physical training)
• 60 sessions at an independent hard chamber clinic: $12,000-$36,000 (at $200-$600/session)
• Home soft chamber purchase: $4,500-$15,000 one-time cost (unlimited sessions, but lower pressure and evidence)
• Maintenance sessions (weekly): $800-$2,400/month at clinic rates

Frequently Asked Questions

Can a home soft chamber produce anti-aging benefits?

There is no published evidence that soft chambers at 1.3 ATA produce the telomere lengthening or senescent cell reduction documented in the Efrati study at 2.0 ATA. Home soft chambers may provide general wellness benefits (improved energy, sleep, recovery), but claiming anti-aging effects based on hard chamber research is not supported.

How often should I do HBOT for longevity?

The Efrati aging study used 60 sessions, 5 days per week, over 12 weeks. There is no established maintenance protocol. Some longevity-focused users do 1-2 sessions per week ongoing. The optimal frequency for maintaining benefits has not been studied in controlled trials.

Is HBOT better than other anti-aging interventions?

HBOT is the only intervention shown to both lengthen telomeres and clear senescent cells in a controlled human study. Pharmaceutical senolytics (D+Q, fisetin) target senescent cells but do not affect telomeres. Rapamycin targets mTOR signaling but not telomeres directly. HBOT addresses both hallmarks of aging through a single intervention. Whether this translates to meaningful lifespan or healthspan extension remains to be demonstrated.

Sources

• Efrati S, et al. “Hyperbaric oxygen therapy increases telomere length and decreases immunosenescence in isolated blood cells.” Aging, 2020.
• Hadanny A, et al. “Physical enhancement of older adults using hyperbaric oxygen.” Scientific Reports, 2024.
• Efrati S, et al. “Reflections on the neurotherapeutic effects of hyperbaric oxygen.” Expert Review of Neurotherapeutics, 2022.